A study to test the Efficacy, Safety, and Tolerability of a medication in Adult and Adolescent Subjects with Non-Segmental Vitiligo
The medication has been approved to be used in the US for other conditions since 2019.
The study lasts about 3 years, including 20 clinic visits.
Criteria:Be 12 years or older
Have a diangosis of Non-Segmental Vitiligo
Have been on treatment that has failed to work or control the disease.